Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Windtree Therapeutics Inc changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 8 | 15 | +7 |
| Shares | 163.0K | 313.7K | +150.6K (+92.4%) |
| Value | $389.7K | $108.7K | −$281.0K (−72.1%) |
New holders (10)
Institutions that held Windtree Therapeutics Inc at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 119,266 | $41.7K | 0.00% |
| Geode Capital Management, LLC | 59,167 | $20.7K | 0.00% |
| XTX Topco Ltd | 19,456 | $6.80K | 0.00% |
| Two Sigma Investments, LP | 14,449 | $5.05K | 0.00% |
| Cubist Systematic Strategies, LLC | 13,696 | $4.78K | 0.00% |
| Goldman Sachs Group Inc | 12,326 | $4.30K | 0.00% |
| HRT Financial LP | 11,057 | $3.00K | 0.00% |
| SBI Securities Co., Ltd. | 62 | $22 | 0.00% |
| BlackRock, Inc. | 6 | $2 | 0.00% |
| Wells Fargo & Company | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held Windtree Therapeutics Inc at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Armistice Capital, LLC | 157,000 | $375.2K |
| Morgan Stanley | 3,712 | $8.87K |
| IFP Advisors, Inc | 1 | $2 |